Regular aspirin use significantly reduced risk of cancer, metastasis and cancer mortality, findings from the largest-ever analyses exploring the drug’s effects on cancer indicate. Overall, aspirin users had a 38% reduced risk of colorectal and other gastrointestinal cancers compared with nonusers. Mortality risk was 15% lower and metastasis was 35% more »
A transhumanism book about your future